Escaline
Names
Preferred IUPAC name
2-(4-Ethoxy-3,5-dimethoxyphenyl)ethan-1-amine
Other names
3,5-Dimethoxy-4-ethoxy-phenethylamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C12H19NO3/c1-4-16-12-10(14-2)7-9(5-6-13)8-11(12)15-3/h7-8H,4-6,13H2,1-3H3 checkY
    Key: RHOGRSKNWDNCDN-UHFFFAOYSA-N checkY
  • InChI=1/C12H19NO3/c1-4-16-12-10(14-2)7-9(5-6-13)8-11(12)15-3/h7-8H,4-6,13H2,1-3H3
    Key: RHOGRSKNWDNCDN-UHFFFAOYAR
  • NCCC1=CC(OC)=C(OCC)C(OC)=C1
  • O(c1c(OC)cc(cc1OC)CCN)CC
Properties
C12H19NO3
Molar mass 225.28 g/mol
Melting point 165 to 166 °C (329 to 331 °F; 438 to 439 K) (hydrochloride)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

Escaline (3,5-methoxy-4-ethoxyphenethylamine) is a psychedelic drug and entheogen of the phenethylamine class of compounds. Escaline was first synthesized and reported in the scientific literature by Benington, et al., in 1954, but was later re-examined in the laboratory of David E. Nichols, who prepared a series of mescaline analogues that included escaline, proscaline, and isoproscaline. The effects of this and related mescaline analogues in humans were first described by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin lists the dosage range as 40 to 60 mg of hydrochloride salt, consumed orally.[1] The duration of action was stated to be 8–12 hours.

Escaline is the phenethylamine analog of 3C-E and the 4-ethoxy analog of mescaline.

Escaline is illegal in Sweden as of 26 January 2016.[2]

Escaline is a Schedule I controlled substance (DEA #7930) in the United States as it is a positional isomer of TMA (3,4,5-trimethoxyamphetamine).[3]

References

  1. ↑ PiHKAL entry
  2. ↑ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
  3. ↑ (PDF) https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf. {{cite web}}: Missing or empty |title= (help)

See also


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.